World's Best Scientists 2026 revealed!
Journal of Pathology
H-index 45

Journal of Pathology

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 371 381 282 40

Additional Metrics

Number of Best Scientists*: 718
Documents by Best Scientists*: 436
Top 100 Ranked Scientists*: 17
SCIMAGO H-index: 214
SCIMAGO SJR: 2.16
Impact Factor: 5.2

Overview

Top Research Topics at The Journal of Pathology?

The journal tackles a plethora of topics, such as Pathology, Cancer research, Internal medicine, Immunohistochemistry and Immunology. In addition to Pathology research, it aims to explore topics under Molecular biology, Metastasis and Adenocarcinoma. The research on Cancer research featured in the journal combines topics in other fields like Carcinogenesis, Cancer, Breast cancer, Cell growth and Mutation.

Internal medicine research presented in the journal encompasses a variety of subjects, including Gastroenterology, Endocrinology and Oncology. Immunology research is the primary subject tackled in The Journal of Pathology with a focus on Inflammation.

  • Pathology (45.45%)
  • Cancer research (19.84%)
  • Internal medicine (13.21%)

What are the most cited papers published in the journal?

  • Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. (7095 citations)
  • Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis (3048 citations)
  • Cellular and molecular mechanisms of fibrosis. (2846 citations)

Research areas of the most cited articles at The Journal of Pathology:

The main points discussed in the journal publications deal with Pathology, Cancer research, Immunohistochemistry, Immunology and Internal medicine. The published articles address concerns in the field of Pathology by exploring it in line with topics in Metastasis which intersect with Lymph node subjects. The most cited articles with studies in Internal medicine featured incorporate elements of Endocrinology and Oncology.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Gene
  • Cancer

The previous edition focused in particular on these issues:

The journal mainly deals with areas of study such as Cancer research, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Coronavirus disease 2019 (COVID-19), 2019-20 coronavirus outbreak and Pathological. Topics in Cancer research explored in The Journal of Pathology were investigated in conjunction with research in Cancer, Metastasis, Prostate cancer and Downregulation and upregulation. The Journal of Pathology facilitates discussions on Prostate cancer that incorporate concepts from other fields like Prostate and PTEN.

Topics in Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were tackled in line with various other fields like Pandemic and Virology. The Pathological study which was featured in it aims to expound on the research in Pathology. Immunohistochemistry is a major topic of Pathology research.

The most cited articles from the last journal are:

  • COVID-19: immunopathology, pathophysiological mechanisms, and treatment options. (11 citations)
  • Microglia/macrophages express alternative proangiogenic factors depending on granulocyte content in human glioblastoma. (11 citations)
  • Machine learning-based analysis of alveolar and vascular injury in SARS-CoV-2 acute respiratory failure. (9 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in The Journal of Pathology (based on the number of publications) are:

  • Nicholas A. Wright (63 papers) absent at the last edition,
  • Rosemary A. Walker (57 papers) absent at the last edition,
  • Richard Poulsom (52 papers) absent at the last edition,
  • Jorge S. Reis-Filho (52 papers) published 1 paper at the last edition,
  • Ian O. Ellis (43 papers) published 1 paper at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in The Journal of Pathology (based on the number of publications) are:

  • University of Cambridge (183 papers) published 3 papers at the last edition, 3 less than at the previous edition,
  • University of Edinburgh (171 papers) published 2 papers at the last edition, 2 less than at the previous edition,
  • John Radcliffe Hospital (170 papers) absent at the last edition,
  • University of Birmingham (151 papers) published 2 papers at the last edition, 1 less than at the previous edition,
  • University of Manchester (143 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 13.61% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 14.17% were posted by at least one author from the top 10 institutions publishing in the journal. Another 7.09% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 15.75% of all publications and 62.99% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Educational Prerequisites and Pathology Career Outlook

For those considering a career in Pathology and contributing to the rich research featured in The Journal of Pathology, there are important prerequisites and considerations. Earning a medical degree is the first step which generally requires an undergraduate degree with a heavy emphasis on basic sciences such as biology and chemistry. Once the degree has been achieved, candidates are required to pass licensing examinations to legally practice medicine. To specialize in Pathology, the next step would be to complete a residency in this field, acquiring the necessary skills and experiences in laboratories and hospital settings. Pathologists, in the course of their training, develop a precise understanding of the causes of diseases and the ways in which they affect the human body. Those who also wish to venture into research or teaching professions often complete a fellowship in their area of interest. For instance, if you're in South Carolina, you can review the south carolina nursing license requirements for a detailed guide on advancing your medical career in this state. It's crucial to keep in mind that licensing and certification requirements may vary from one region to another. As it pertains to job prospects, the U.S. Bureau of Labor Statistics projected employment of Medical Scientists, which includes Pathologists, to grow 16 percent from 2020 to 2030, much faster than the average for all occupations. This growth is partly due to an increased need for innovative research to improve human health. Remember, before embarking on this journey, it's important to explore the various pathways in medicine, consider your areas of interest, and align these with your long-term career goals. After all, a career in Pathology is not only about researching diseases, but also about improving patient health outcomes and changing lives.

Top Publications

  • Angiotensin?converting enzyme 2 (ACE2), SARS?CoV?2 and the pathophysiology of coronavirus disease 2019 (COVID?19)

    Arno R. Bourgonje;Amaal Eman Abdulle;Wim Timens;Jan Luuk Hillebrands

    (2020)
    1118 Citations
  • Clinicopathological and molecular characterisation of 'multiple-classifier' endometrial carcinomas.

    Alicia León‐Castillo;Ester Gilvazquez;Ester Gilvazquez;Remi Nout;Vincent T.H.B.M. Smit

    (2020)
    282 Citations
  • Interpretation of somatic POLE mutations in endometrial carcinoma.

    Alicia León-Castillo;Heidi Britton;Melissa K McConechy;Jessica N McAlpine

    (2020)
    276 Citations
  • p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies

    Naveena Singh;Anna M Piskorz;Tjalling Bosse;Mercedes Jimenez-Linan

    (2020)
    239 Citations
  • The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice

    Paula I Gonzalez‐Ericsson;Elisabeth S Stovgaard;Luz F Sua;Emily Reisenbichler

    (2020)
    194 Citations
  • Recent advances in chronic obstructive pulmonary disease pathogenesis: from disease mechanisms to precision medicine.

    Corry-Anke Brandsma;Maarten Van den Berge;Tillie-Louise Hackett;Tillie-Louise Hackett;Guy Brusselle;Guy Brusselle

    (2020)
    168 Citations
  • Independent real-world application of a clinical-grade automated prostate cancer detection system.

    Leonard M da Silva;Emilio M Pereira;Paulo Go Salles;Ran Godrich

    (2021)
    162 Citations
  • A streamlined mass spectrometry-based proteomics workflow for large scale FFPE tissue analysis

    Fabian Coscia;Fabian Coscia;Sophia Doll;Jacob Mathias Bech;Lisa Schweizer

    (2020)
    146 Citations
  • COVID-19: immunopathology, pathophysiological mechanisms, and treatment options.

    Larissa E. van Eijk;Mathijs Binkhorst;Arno R. Bourgonje;Annette K. Offringa

    (2021)
    115 Citations
  • Neutrophil extracellular traps drive epithelial–mesenchymal transition of human colon cancer

    (2021)
    110 Citations

Related Online Degrees & Career Pathways

For those interested in healthcare careers related to medicine, exploring nursing degrees is a popular pathway. Many students pursue programs like the online direct entry MSN to transition into advanced nursing roles quickly, especially for non-nurses seeking a fast track.

When evaluating nursing programs, affordability and value are crucial factors. The comparison between programs highlights the best value nursing education online wgu, which many find offers quality education combined with reasonable tuition.

For registered nurses pursuing advanced degrees, bridge programs provide a seamless path from BSN to MSN. Finding the right program matters, especially when considering cost-effectiveness, as seen in the bsn to msn online options available to students nationwide.

Lastly, some working nurses prefer programs with more flexible clinical requirements. The rn to bsn online no clinicals programs accommodate this need, allowing students to advance their education without in-person clinical hours, ideal for busy professionals.

Best Scientists Contributing to This Journal

Recently Published Articles